TFX - Teleflex Incorporated
| Previous Close | 334.96 |
| Open | 336.63 |
| Bid | 0.00 x 1100 |
| Ask | 0.00 x 900 |
| Day's Range | 330.62 - 336.63 |
| 52 Week Range | 226.02 - 337.96 |
| Volume | 203,229 |
| Avg. Volume | 261,161 |
| Market Cap | 15.301B |
| Beta (3Y Monthly) | 1.11 |
| PE Ratio (TTM) | 83.82 |
| EPS (TTM) | 3.95 |
| Earnings Date | Jul 31, 2019 - Aug 5, 2019 |
| Forward Dividend & Yield | 1.36 (0.41%) |
| Ex-Dividend Date | 2019-05-14 |
| 1y Target Est | 341.27 |
- Zacks•22 hours ago
Chemed's Roto-Rooter & VITAS Robust, Acuity Mix Shift Weak
Chemed's (CHE) VITAS shows higher adoption via an expanded average daily census. Also, the Roto-Rooter's business grows on the back of strong core plumbing and drain cleaning service segments.
- Zacks•22 hours ago
Masimo (MASI) Hits a 52-Week High on Solid Growth Drivers
Masimo (MASI) gains from expansion of product portfolio and recent regulatory approvals.
- Zacks•23 hours ago
Abbott MitraClip G4 Gets FDA Nod, Valve Repair Options Expand
The FDA approval for MitraClip G4 is expected to enhance Abbott's (ABT) cardiac treatment portfolio.
- Zacks•2 days ago
Here's Why You Should Hold Onto Neogen (NEOG) Stock Now
Investors' trust continues to be high in Neogen (NEO), thanks to strength in its Food Safety and Genomic businesses.
- Zacks•5 days ago
TFX or STE: Which is a Better Investment Pick Right Now?
STERIS (STE) scores higher than Teleflex (TFX) when it comes to valuation and one-year price performance.
- Zacks•6 days ago
Illumina (ILMN) Grows on Innovation & International Growth
Illumina (ILMN) is benefiting from sturdy demand for sequencing and array systems as well as consumables and services.
- Zacks•6 days ago
NuVasive (NUVA) Launches Pulse Integrated Technology Platform
The launch of this system is in sync with NuVasive's (NUVA) endeavor to deliver end-to-end solutions that offer predictable clinical and economic outcomes in spine surgery.
- Zacks•7 days ago
Boston Scientific's Global Growth Robust Amid Currency Woe
Boston Scientific (BSX) is currently pinning hopes on a stronger performance in China, backed by the recent approval of SYNERGY in the country.
- Zacks•7 days ago
Medtronic Releases Positive Results of LATERAL Clinical Trial
Positive outcomes prove to be a major breakthrough for Medtronic (MDT) in the growing field of ventricular assist devices.
- Business Wire•7 days ago
Teleflex announces Presentations about its UroLift® System treatment at the annual British Association of Urologists (BAUS) meeting
4D surgical techniques for insertion of UroLift System implants and a single-centre study showing significant cost savings with the use of the UroLift System treatment compared with traditional surgery. Teleflex Incorporated (TFX) today thanked its United Kingdom-based Physician Advocates for their Poster Presentations highlighting the UroLift® System, as well as real world proof of its cost effectiveness, at this year’s BAUS meeting which finished on June 26th. The first Presentation, by Dr. Mark Rochester*, Consultant Urologist from Norfolk and Norwich University Hospital, shared promising, early results of the UroLift System treatment of BPH patients with acute urinary retention.
- Zacks•8 days ago
ResMed (RMD) Rides on Strong SaaS Growth & New Product Suite
ResMed's (RMD) new product menu and an array of strategies are likely to benefit from the sleep-disordered breathing market. This should further drive its short-term performance.
- Zacks•8 days ago
Integra Partners AI-Driven Data Analytics Firm in Wound Care
Integra LifeSciences (IART) expects its partnership with Tissue Analytics to be perfectly strategic as the latter's software solutions automatically derive high quality data from clinical pictures.
- Zacks•8 days ago
Phibro Animal Sees Crucial Progress in ASF Vaccine Development
The identification of a group of peptides and proteins is a remarkable step toward Phibro's (PAHC) development of a solution for ASF.
- Zacks•8 days ago
Fresenius Set for Global Expansion of Research Activities
Fresenius Medical Care (FMS) aims to expand the scope of its clinical research activities through an integration move.
- GlobeNewswire•8 days ago
Teleflex Announces Publication of a Large Real-World Study Confirming Results from Controlled Clinical Studies of the UroLift® System
WAYNE, Pa., July 09, 2019 -- Teleflex Incorporated (NYSE: TFX) today announced the publication of positive results from a multi-center study reaffirming the safety and.
- Zacks•9 days ago
Illumina (ILMN) Hits 52-Week High, Can the Run Continue?
Illumina (ILMN) gains from expansion of its product portfolio and strategic partnership.
- Zacks•9 days ago
CVS Health Banks on Aetna Prospects, Omnicare May Disappoint
CVS Health's (CVS) Aetna integration synergies bode well for the stock.
- Zacks•9 days ago
Boston Scientific to Sell Bead Suit, Make Way for BTG Buyout
The sale of oncology bead products by Boston Scientific (BSX) is expected to be among the last steps undertaken by the company to obtain Federal Trade Commission's approval for BTG buyout.
- Zacks•9 days ago
Here's Why CVS Health (CVS) Should Be in Your Portfolio
Investors' trust continues to be high in CVS Health (CVS), thanks to strength in its PBM business.
- Simply Wall St.•12 days ago
Should You Be Concerned About Teleflex Incorporated's (NYSE:TFX) ROE?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
- Zacks•12 days ago
Here's Why Chemed (CHE) Should Remain in Your Portfolio Now
Investors' trust in Chemed (CHE) continues to be high, banking on its sturdy segmental performance.
- Zacks•12 days ago
Edwards Lifesciences Recalls Heart Device on Balloon Rupture
Shares of Edwards Lifesciences (EW) decline post product recall news.
- Moody's•20 days ago
Teleflex Incorporated -- Moody's announces completion of a periodic review of ratings of Teleflex Incorporated
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Teleflex Incorporated and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.
- Zacks•22 days ago
Teleflex (TFX) Shares Down on Respiratory Care Product Recall
Teleflex (TFX) issued a statement saying consumers who own the tampered product should immediately discontinue use and return all affected products.
- Reuters•23 days ago
Teleflex recalls breathing tubes worldwide after reports of 4 deaths
